Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
For instance, would you incorporate use of Oncotype DX in this patient population to guide decision making on the use of regional nodal irradiation?
Answer from: Radiation Oncologist at Community Practice
Currently, I don’t offer PMRT for T1 and T2 disease with micromets unless triple negative or a multitude of adverse factors Mamtani et al., PMID 28429197
Sign in or Register to read more